(Q44058771)

29 November 2017

title

ADVANCE--Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline (English)

1 reference

29 November 2017

1 reference

ADVANCE Collaborative Group

series ordinal

1

1 reference

29 November 2017

language of work or name

1 reference

1 July 2005

1 reference

29 November 2017

1 reference

29 November 2017

volume

22

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

882-888

1 reference

Long-term complications of diabetes mellitus

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01596.X

10.1111/J.1464-5491.2005.01596.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference